Structure |
Chemical Name |
CAS |
MF |
|
Mixture of Lamivudine Impurity Ⅳ and Impurity Ⅴ |
|
|
|
2-Ethoxybenzimidohydrazide |
889943-46-8 |
C9H13N3O |
|
(E)-2-(6-(methoxycarbonyl)-2-oxoindolin-3-ylidene)-2-phenylacetic acid |
|
C18H13NO5 |
|
2-(3-メチル-5-オキソ-1-フェニル-4,5-ジヒドロ-1H-ピラゾール-4-イル)プロパン-2-スルホン酸 |
1323485-71-7 |
C13H16N2O4S |
|
Ondansetron Impurity B |
|
|
|
LeflunoMide EP IMpurity F |
1403564-06-6 |
C12H9F3N2O2 |
|
8-Epi-cyanocobalamin |
41325-63-7 |
C63H88CoN14O14P |
|
Lamivudine Impurity 2 |
200396-21-0 |
C18H27N3O4S |
|
Lamivudine Impurity 1 |
1235712-40-9 |
C8H11N3O4S |
|
Moxifloxacin Related Impurity 3 |
|
|
|
Bisoprolol EP Impurity Q |
1346604-00-9 |
C16H27NO4 |
|
4'-((1,7'-dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazol-1'-yl)methyl)biphenyl-2-carboxylic acid |
|
|
|
Trelagliptin IMpurity 33 |
|
|
|
Estradiol Impurity 1 |
57780-81-1 |
C18H24O4 |
|
Metoprolol IMpurity L |
|
C15H25NO3 |
|
Itraconazole iMpurity D |
|
|
|
Teneligliptin Impurity 14 |
|
|
|
3-amino-2-chloroacrolein |
221615-73-2 |
C3H4ClNO |
|
Ampicillin EP Impurity P |
|
|
|
5-Heptenoic acid, 7-[(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-, 1-methylethyl ester, (5E)- |
1563176-58-8 |
C25H34F2O5 |
|
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R,5S)-tetrahydro-4-hydroxy-5-methyl-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester |
477877-98-8 |
C26H40O5 |
|
1H-1,2,4-Triazole-1-ethanol, α-(2,4-difluorophenyl)-α-(1H-1,2,4-triazol-1-ylmethyl)-, 4-oxide |
1997296-62-4 |
C13H12F2N6O2 |
|
para-Hydroxy L-Milnacipran |
688738-11-6 |
C15H22N2O2 |
|
Varenicline Impurity 9 |
|
|
|
Elagolix Sodium impurity3 |
|
|
|
Epinephrine Impurity 4 |
94217-53-5 |
C9H13NO3 |
|
(trans)-4-((2-amino-3,6-dibromobenzyl)amino)cyclohexanol |
|
C13H18Br2N2O |
|
(R)-2-(3-(diisopropylamino)-1-phenylpropyl)phenol |
|
C21H29NO |
|
Dexamethasone EP impurities F |
|
|
|
D-Ribofuranose, 1-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,3,5-tris-O-(phenylmethyl)- |
1355049-94-3 |
C32H32N4O5 |
|
Delamanid Impurity 1 |
|
|
|
N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-3-hydroxyphenyl)-1,1-cyclopropanedicarboxamide |
1628530-41-5 |
C28H24FN3O6 |
|
Oseltamivir Impurity Mixture (MW:486 Da) |
|
|
|
2,2'-(7-((2R,3S)-1,3,4-trihydroxybutan-2-yl)-10-((2S,3R)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,4-diyl)diacetic acid Gd3+ |
|
|
|
(R)-Ethyl 3-(bromomethyl)hexanoate |
1956435-91-8 |
C9H17BrO2 |
|
Flucloxacillin Sodium EP Impurity B |
|
|
|
4-PYRIDIN-4-YL-BUTYRIC ACID |
102878-73-9 |
C9H11NO2 |
|
1-Ethyl-2-[[(2-methoxy-5-sulphamoyl |
|
|
|
2-(4-Bromo-3-formylphenoxy)-benzonitrile |
1160182-46-6 |
C14H8BrNO2 |
|
Carbetocin S-Oxide I |
|
|
|
Dolutegravir Impurity 15 |
|
|
|
PeraMpanel |
380919-67-5 |
C23H15N3O2 |
|
Empagliflozin Impurity 86 |
|
|
|
Olopatadine Impurity 11 HBr |
4174-84-9 |
C21H24Br2NP |
|
Iohexol Impurity P |
|
|
|
Sulbactam Impurity 2 |
111790-24-0 |
C8H13NO6S |
|
Vortioxetine Impurity 8 HCl |
2137722-14-4 |
C18H23ClN2S |
|
Relugolix Impurity 1 |
|
|
|
3-アミノ-4-ピラゾールカルボニトリル |
16617-46-2 |
C4H4N4 |
|
BenzaMide, 3,4-bis(cyclopropylMethoxy)-N-(3,5-dichloro-4-pyridinyl)- |
1391052-24-6 |
C20H20Cl2N2O3 |
|
1-(4-アセチルフェニル)-2-メチル-1-プロパノン |
103931-20-0 |
C12H14O2 |
|
ButanaMide, 4-hydroxy-N-(1-Methylethyl)- |
42042-66-0 |
C7H15NO2 |
|
5H-chroMeno[2,3-b]pyridin-7-ylacetic acid |
52549-07-2 |
C14H11NO3 |
|
IMp. B (EP): (2RS,4S)-2-[[[[3-(2-Chloro-6-fluorophenyl)-5-Methylisoxazol-4-yl]carbonyl]aMino]Methyl]-5,5-diMethyl- thiazolidine-4-carboxylic Acid (Penilloic Acids of Flucloxacillin) |
|
|
|
Oseltamivir Diastereomer III HCl |
2413185-95-0 |
C16H28N2O4 |
|
Rocuronium bromide impurity (3,16,17-triol) |
|
C23H39NO4 |
|
4-(4-amino-3-chlorophenoxy)-7-methoxyquinoline-6-carboxylic acid |
|
C17H13ClN2O4 |
|
Ornidazole Impurity 26 |
|
|
|
Pitavastatin Impurity 73 |
|
|
|
Furosemide Impurity 24 |
|
|
|
Brivaracetam Impurity 34 |
|
|
|
1-((2R,3R)-3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-4-(1-(((3-(hydroxymethyl)pyridin-2-yl)(methyl)carbamoyl)oxy)ethyl)-1H-1,2,4-triazol-4-ium chloride |
|
|
|
1H-1,2,4-Triazole-1-propanol, α-(2,4-difluorophenyl)-α-(1H-1,2,4-triazol-1-ylmethyl)- |
1222655-38-0 |
C14H14F2N6O |
|
IMp. C (EP): (4-(DiphenylMethyl)-1,1-bis[(E)-3-phenylprop-2-enyl]piperaziniuM Chloride |
95062-18-3 |
C35H35ClF2N2 |
|
IMp. E (EP): 4-AMino-5-(ethylsulphonyl)-2-Methoxybenzoic Acid |
|
|
|
1-ニトロ-3,7-ジメチルアダマンタン |
6588-68-7 |
C12H19NO2 |
|
6-O-Benzyl-4-dehydroxy-4-diMethylphenylsilyl Entecavir |
649761-24-0 |
C27H31N5O2Si |
|
Desisobutyl-n-butyl BortezoMib |
1104011-35-9 |
C19H25BN4O4 |
|
2-aMino-4-Methoxy-5-(3-Morpholinopropoxy)benzaMide |
246512-44-7 |
C15H23N3O4 |
|
N-(4,6-dichloro-2-(propylthio)pyriMidin-5-yl)forMaMide |
1402150-28-0 |
C8H9Cl2N3OS |
|
Ebastine IMpurity G |
1429071-65-7 |
C32H39NO3 |
|
((R)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butyl)boronic acid |
1132709-15-9 |
C19H25BN4O4 |
|
N-[(1S)-2-アミノ-2-オキソ-1-(フェニルメチル)エチル]-2-ピラジンカルボキサミド |
289472-80-6 |
C14H14N4O2 |
|
(3aS,4R,6S,6aR)-6-AMinotetrahydro-2,2-diMethyl-4H-cyclopenta-1,3-dioxol-4-ol |
592533-90-9 |
C8H15NO3 |
|
(1R,2R,3S,5R)-3-(7-((1S,2R)-2-(3,4-difluorophenyl)cyclopropylaMino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
2096989-55-6 |
C23H28F2N6O4S |
|
Rivaroxaban iMpurity |
1616563-62-2 |
C15H17N3O5 |
|
cefoxitin iMpurity D |
|
|
|
3-Morpholinone, 4-(2,4-diaMinophenyl)- |
482308-13-4 |
C10H13N3O2 |
|
ボセンタン関連化合物B (4-(TERT-ブチル)-N-[6-ヒドロキシ-5-(2-メトキシフェノキシ)-(2,2'-ビピリミジン)-4-イル]ベンゼンスルホンアミド) |
174227-14-6 |
C25H25N5O5S |
|
BenzaMide, N-[1-(3,5-di-O-benzoyl-2-C-Methyl-β-D-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyriMidinyl]- |
863329-62-8 |
C31H27N3O8 |
|
Fosfluconazole iMpurity |
|
|
|
Tofacitinib Impurity H |
|
|
|
3',6'-Dehydroclindamycin |
1440605-51-5 |
C18H31ClN2O5S |
|
Cefradine Impurity F |
|
|
|
Mirabegron Impurity |
1684452-83-2 |
C26H28N6O3S2 |
|
1-メチル-1H-インドール-6-オール |
130570-60-4 |
C9H9NO |
|
2-(2-ヒドロキシフェニル)-4-メチルチアゾール-5-カルボン酸エチル |
118485-48-6 |
C13H13NO3S |
|
32-Carboxycyanocobalamin |
121483-62-3 |
C63H87CoN13O15P |
|
Alvimopan Impurity 6 |
|
|
|
Sofosbuvir Impurity28 |
|
|
|
Rivaroxaban Impurity 10 |
|
|
|
Ipragliflozin Impurity 1 |
|
|
|
(17α)-4-Bromo-17-hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile |
98149-13-4 |
C20H24BrNO2 |
|
316173-27-0 |
316173-27-0 |
C17H28N2O5 |
|
Irbesartan Impurity 7 |
|
C25H28N6O |
|
Voriconazole Impurity 2 |
|
|
|
Safinamide Impurity 1 |
|
|
|
Caspofungin impurit 2 |
|
|
|
Lamivudine impurity 1 |
|
|
|
Raltitrexed Impurity 1 |
1378372-01-0 |
C10H10N2O2 |